EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 21-Jun-2026 21:16 ET (22-Jun-2026 01:16 GMT/UTC)

Next-generation KRAS G12C inhibitor elisrasib elicited promising response rates in patients with advanced lung cancer

American Association for Cancer Research
Reports and Proceedings

Treatment with the investigational next-generation KRAS-G12C inhibitor elisrasib led to clinical benefit in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12C mutation and whose disease progressed after prior therapies, according to results presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22.

Meeting: American Association for Cancer (AACR) Annual Meeting 2026

New antibody-drug conjugate shows clinical benefit for advanced platinum-resistant ovarian cancer

American Association for Cancer Research
Reports and Proceedings

Patients with advanced platinum-resistant ovarian cancer whose disease had progressed on standard therapy experienced clinical benefit when treated with the investigational antibody-drug conjugate (ADC) QLS5132, according to results from a phase I clinical trial presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22.

Meeting: American Association for Cancer (AACR) Annual Meeting 2026

Investigational KRAS(ON) inhibitor zoldonrasib showed effective and durable responses in patients with advanced G12D-mutated lung cancer

American Association for Cancer Research
Reports and Proceedings

The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favorable safety profile in patients with previously treated non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12D mutation, according to an updated trial analysis presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22.

Meeting: American Association for Cancer (AACR) Annual Meeting 2026

Long-term use of immunotherapy may be safe for patients with alveolar soft part sarcoma

American Association for Cancer Research
Reports and Proceedings

Long-term adverse events were rare and manageable among patients with alveolar soft part sarcoma (ASPS), which primarily affects adolescents and young adults, who received immunotherapy beyond the standard two years, according to results from a phase II clinical trial presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22.

Meeting: American Association for Cancer (AACR) Annual Meeting 2026

AI: the future of breast cancer diagnosis and treatment

China Anti-Cancer Association
Peer-Reviewed Publication

Artificial intelligence (AI) is transforming breast cancer care by improving diagnosis, treatment planning, and drug development.

Journal: Cancer Biology & Medicine

Catching cancer clusters without breaking them

Aerospace Information Research Institute, Chinese Academy of Sciences
Peer-Reviewed Publication

Cancer clues in pleural effusions are often rare, fragile, and easy to miss. Single malignant tumor cells (MTCs) can help confirm malignancy, but intact malignant tumor cell clusters (MTCCs) may reveal even more about aggressive disease and metastatic risk.

Journal: Microsystems & Nanoengineering

Dana-Farber researchers to present more than 50 research studies at American Association for Cancer Research Annual Meeting 2026

Dana-Farber Cancer Institute
Meeting Announcement

Dana-Farber Cancer Institute researchers will present more than 50 studies at the American Association for Cancer Research (AACR) Annual Meeting 2026, from April 17-22, in San Diego, Calif. The meeting is the focal point of the cancer research community, where leading scientists, clinicians, health care professionals, survivors, patients and advocates share the latest advances in cancer science and medicine.

Meeting: American Association for Cancer (AACR) Annual Meeting 2026

Gut bacteria predict skin cancer recurrence, but only when matched for ‘microbial fingerprint’

NYU Langone Health / NYU Grossman School of Medicine
Peer-Reviewed Publication

A new study revealed that differences in the amount of key bacterial groups in the gut accurately predicted cancer recurrence when patients were analyzed in a new way.

Journal: Cell

University of Cincinnati Cancer Center presents research abstracts at AACR 2026

University of Cincinnati
Meeting Announcement

University of Cincinnati Cancer Center researchers will present abstracts at the American Association for Cancer Research Annual Meeting 2026 April 17 to 22 in San Diego.

Meeting: American Association for Cancer (AACR) Annual Meeting 2026

Eating fruits, vegetables and whole grains may increase chance of early onset lung cancer

University of Southern California - Health Sciences
Reports and Proceedings

New research from USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, suggests that eating fruits, vegetables and whole grains may increase chance of early onset lung cancer.

73
74
75
76
77